Literature DB >> 7717399

Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

N Janicic1, Z Pausova, D E Cole, G N Hendy.   

Abstract

Missense mutations in the calcium-sensing receptor (CaR) gene have previously been identified in patients with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). We studied family members of a Nova Scotian deme expressing both FHH and NSHPT and found, by PCR amplification of CaR gene exons, that FHH individuals were heterozygous and NSHPT individuals were homozygous for an abnormally large exon 7. This is due to an insertion at codon 877 of an Alu-repetitive element of the predicted-variant/human-specific-1 subfamily. It is in the opposite orientation to the CaR gene and contains an exceptionally long poly(A) tract. Stop signals are introduced in all reading frames within the Alu sequence, leading to a predicted shortened mutant CaR protein. The loss of the majority of the CaR carboxyl-terminal intracellular domain would dramatically impair its signal transduction capability. Identification of the specific mutation responsible for the FHH/NSHPT phenotype in this community will allow rapid testing of at-risk individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717399      PMCID: PMC1801194     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Evolution of the master Alu gene(s).

Authors:  M R Shen; M A Batzer; P L Deininger
Journal:  J Mol Evol       Date:  1991-10       Impact factor: 2.395

2.  Isolation and sequence analysis of a cDNA clone encoding the fifth complement component.

Authors:  A B Lundwall; R A Wetsel; T Kristensen; A S Whitehead; D E Woods; R C Ogden; H R Colten; B F Tack
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

3.  Familial benign hypercalcemia.

Authors:  T P Foley; H C Harrison; C D Arnaud; H E Harrison
Journal:  J Pediatr       Date:  1972-12       Impact factor: 4.406

4.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 5.  Repetitive sequences in eukaryotic DNA and their expression.

Authors:  W R Jelinek; C W Schmid
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

6.  The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds.

Authors:  S J Marx; M F Attie; M A Levine; A M Spiegel; R W Downs; R D Lasker
Journal:  Medicine (Baltimore)       Date:  1981-11       Impact factor: 1.889

7.  X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Authors:  D G Bichet; G N Hendy; M Lonergan; M F Arthus; S Ligier; Z Pausova; R Kluge; H Zingg; P Saenger; E Oppenheimer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

8.  An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds.

Authors:  S J Marx; M F Attie; A M Spiegel; M A Levine; R D Lasker; M Fox
Journal:  N Engl J Med       Date:  1982-02-04       Impact factor: 91.245

9.  Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity.

Authors:  H Heath; C E Jackson; B Otterud; M F Leppert
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

10.  The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families.

Authors:  Y H Chou; E M Brown; T Levi; G Crowe; A B Atkinson; H J Arnqvist; G Toss; G E Fuleihan; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

View more
  28 in total

Review 1.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 2.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy.

Authors:  A Ferlini; N Galié; L Merlini; C Sewry; A Branzi; F Muntoni
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

4.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

5.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M Bai; N Janicic; S Trivedi; S J Quinn; D E Cole; E M Brown; G N Hendy
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells.

Authors:  S H Pearce; M Bai; S J Quinn; O Kifor; E M Brown; R V Thakker
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

7.  Metachromatic leucodystrophy in three families from Nova Scotia, Canada: a recurring mutation in the arylsulphatase A gene.

Authors:  M B Coulter-Mackie; L Gagnier; M J Beis; D A Applegarth; D E Cole; K Gordon; M D Ludman
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

8.  An Alu-mediated rearrangement as cause of exon skipping in Hunter disease.

Authors:  Verena Ricci; Stefano Regis; Marco Di Duca; Mirella Filocamo
Journal:  Hum Genet       Date:  2003-02-11       Impact factor: 4.132

9.  De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.

Authors:  M Oldridge; E H Zackai; D M McDonald-McGinn; S Iseki; G M Morriss-Kay; S R Twigg; D Johnson; S A Wall; W Jiang; C Theda; E W Jabs; A O Wilkie
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  De novo insertion of an Alu sequence in the coding region of the CLCN5 gene results in Dent's disease.

Authors:  Felix Claverie-Martin; Hilaria González-Acosta; Carlos Flores; Montserrat Antón-Gamero; Víctor García-Nieto
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.